Lunai Bioworks Inc. Company Profile
NASDAQ: LNAIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 1.12 0.00%
Lunai Bioworks at a glance
Lunai Bioworks Inc. (NASDAQ: LNAI) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Los Angeles, CA. Lunai Bioworks is led by Mr. David H. Weinstein and employs about 29 people. At a market capitalization of $5.1 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001527728, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Lunai Bioworks do?
Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients. The company was formerly known as Renovaro Inc. and changed its name to Lunai Bioworks Inc. in August 2025. Lunai Bioworks Inc. is headquartered in Los Angeles, California.
Business description based on the company's public filings.
Company information
- Legal name
- Lunai Bioworks Inc.
- Ticker
- NASDAQ: LNAI
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. David H. Weinstein
- Employees
- 29
- Headquarters
- 2080 Century Park East, Los Angeles, CA, United States
- Phone
- 305 918 1980
- Website
- lunaibioworks.com
- Market cap
- $5.08M
- SEC CIK
- 0001527728
Companies similar to Lunai Bioworks
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| RDHLRedhill Biopharma Ltd. ADR | 0.578 | +21.94% | $5.14M | vs LNAI |
| XBIOXenetic Biosciences Inc. | 2.12 | -4.07% | $4.97M | vs LNAI |
| XTLBXTL Biopharmaceuticals Ltd. ADR | 1.99 | +0.51% | $4.89M | vs LNAI |
| DRMADermata Therapeutics Inc. | 1.07 | -4.46% | $5.30M | vs LNAI |
| BGMSBio Green Med Solution Inc. | 0.821 | -3.41% | $5.44M | vs LNAI |
| NCNANuCana plc ADR | 1.13 | -0.88% | $4.70M | vs LNAI |
| ENLVEnlivex Ltd. | 0.277 | -10.85% | $5.51M | vs LNAI |
| PPCBPropanc Biopharma Inc. | 0.471 | -5.55% | $4.63M | vs LNAI |